172 related articles for article (PubMed ID: 18712680)
1. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate.
Royuela M; Rodríguez-Berriguete G; Fraile B; Paniagua R
Histol Histopathol; 2008 Oct; 23(10):1279-90. PubMed ID: 18712680
[TBL] [Abstract][Full Text] [Related]
2. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma).
Nuñez C; Cansino JR; Bethencourt F; Pérez-Utrilla M; Fraile B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Histopathology; 2008 Aug; 53(2):166-76. PubMed ID: 18752500
[TBL] [Abstract][Full Text] [Related]
3. The p38 transduction pathway in prostatic neoplasia.
Ricote M; García-Tuñón I; Bethencourt F; Fraile B; Onsurbe P; Paniagua R; Royuela M
J Pathol; 2006 Feb; 208(3):401-7. PubMed ID: 16369914
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma.
Ricote M; Royuela M; García-Tuñón I; Bethencourt FR; Paniagua R; Fraile B
J Urol; 2003 Sep; 170(3):787-90. PubMed ID: 12913698
[TBL] [Abstract][Full Text] [Related]
5. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase.
Takeuchi J; Hirota K; Itoh T; Shinkura R; Kitada K; Yodoi J; Namba T; Fukuda K
Antioxid Redox Signal; 2000; 2(1):83-92. PubMed ID: 11232604
[TBL] [Abstract][Full Text] [Related]
7. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
9. Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-kappaB-mediated gene expression in airway epithelial cells.
Zhou L; Tan A; Iasvovskaia S; Li J; Lin A; Hershenson MB
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):762-9. PubMed ID: 12600818
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
11. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
Ninomiya-Tsuji J; Kishimoto K; Hiyama A; Inoue J; Cao Z; Matsumoto K
Nature; 1999 Mar; 398(6724):252-6. PubMed ID: 10094049
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway.
Jijon H; Allard B; Jobin C
Cell Signal; 2004 Sep; 16(9):1023-32. PubMed ID: 15212763
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells.
Sawai H; Funahashi H; Okada Y; Matsuo Y; Sakamoto M; Yamamoto M; Takeyama H; Manabe T
Med Sci Monit; 2005 Oct; 11(10):BR343-50. PubMed ID: 16192891
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha, inefficient by itself, potentiates IL-1beta-induced PGHS-2 expression in human pulmonary microvascular endothelial cells: requirement of NF-kappaB and p38 MAPK pathways.
Said FA; Werts C; Elalamy I; Couetil JP; Jacquemin C; Hatmi M
Br J Pharmacol; 2002 Aug; 136(7):1005-14. PubMed ID: 12145100
[TBL] [Abstract][Full Text] [Related]
17. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.
Holtmann H; Winzen R; Holland P; Eickemeier S; Hoffmann E; Wallach D; Malinin NL; Cooper JA; Resch K; Kracht M
Mol Cell Biol; 1999 Oct; 19(10):6742-53. PubMed ID: 10490613
[TBL] [Abstract][Full Text] [Related]
20. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
